Loading…
Monday June 16, 2025 10:15am - 10:45am EDT
TBD
Component Type: Session

Clinical trials rely on historical data, causing inefficiencies in site selection, patient matching, and execution. To drive change, the industry must apply the scientific method—testing AI-driven approaches to optimize outcomes. Lokavant leads this shift, improving protocol-matching accuracy by 20% and using predictive analytics. CEO Rohit Nambisan shares real-world evidence of AI’s impact on de-risking trials and accelerating enrollment. Learn why pharma leaders now see AI as a necessity.

Speaker

Speaker
Rohit Nambisan


Speakers
avatar for Rohit Nambisan

Rohit Nambisan

CEO & Co-Founder, Lokavant, United States
Trained as a neuroscientist, Rohit Nambisan is a product executive with experience leading product development organizations in pharma, medical devices, personalized medicine, health IT, healthcare data and analytics, and AI. Prior to co-founding and leading Lokavant, Rohit was most... Read More →
Monday June 16, 2025 10:15am - 10:45am EDT
TBD Walter E. Washington Convention Center 801 Allen Y. Lew Place, NW Washington, DC 20001-3614 USA
  18: InnovationTheaters, Session

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Share Modal

Share this link via

Or copy link